HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume  

 

 

If you want to download the article, please login or register as reader.

2009

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 5 - 14)

Treatment of Opioid Dependence and ADHD/ADD with Opioid Maintenance and Central Stimulants

Blix O., Dalteg A., Nilsson P.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 15 - 22)

Dihydrocodeine for the Treatment of Alcohol Dependence

Ulmer A., Müller M., Frietsch B.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 23 - 30)

Use and Abuse of High-Dose Buprenorphine (HDB) Obtained Without a Prescription: a French Survey

Courty P.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 31 - 34)

A 10-Year Evaluation of Chronic Pain Patients Treated with Opioids

Tennant F.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 35 - 40)

Psychotherapeutic Experiences with Methadone Maintained Patients in the Framework of Multidisciplinary Clinical Institution

Todorov O.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 41 - 42)

Preferences for Buprenorphine/Naloxone (Suboxone®) and Buprenorphine (Subutex®) in Patients Receiving Buprenorphine Maintenance Therapy in France: A Prospective, Multicentre Study

Daulouède J.-P., Caer Y., Galland P., Villeger P., Brunelle E., Bachellier J., Piquet J.-M., Harbonnier J., Leglise Y., Courty P.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 43 - 46)

Coordinating Methadone Treatment Providers and Policymakers: Lessons Learned Over 30 Years

Parrino M. W.

Heroin Addiction and Related Clinical Problems: 2009, 11, 1 (pages: 47 - 48)

En Route to 90% Retention. ‘Active Rehabilitation' in Central Norway

Nordstrand B.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 5 - 8)

Swedish Use and Misuse of the Dole & Nyswander Treatment

Gunne L.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 9 - 20)

Methadone-treated Patients After Switching to Buprenorphine in Residential Therapeutic Communities: An Addiction-specific Assessment of Quality of Life

González-Saiz F., Gómez R. B., Bilbao Acedos I., Lozano Rojas O., Gutiérrez Ortega J.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 21 - 30)

Clinical trial on the use of olanzapine in reducing the consumption of cocaine in Methadone Maintenance Programmes

Vázquez M. L., Castillo I. I., Jiménez-Lerma J. M., Beldarrain J. A. H., Gutiérrez-Fraile M.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 31 - 40)

Voices of Experience: Attitudes and Opinions of Recipients of Unsupervised Injectable Opiate Treatment in the Northwest of England

Orgel M., Wilson A., Leavey R., Sell L., Zador D.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 41 - 46)

Substitution Therapy. A New Problem of Biomedical Ethics and Medical Law

Mendelevich V. D.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 47 - 58)

New Approaches in the Treatment of Opioid Dependency During the Pregnancy

Finnegan L., Winklbaur B., Fischer G., May O., Welle-Strand G.

Heroin Addiction and Related Clinical Problems: 2009, 11, 2 (pages: 59 - 62)

QTc Interval Screening. American Association for the Treatment of Opioid Dependance (AATOD) Policy and Guidance Statement

Parrino M., Aatod Board of Directors

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 5 - 10)

Methadone Treatment in Italy in the Third Millennium: Continuing Fear of Treatment

Maremmani I.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 11 - 28)

Pharmacology and Neurochemistry of Methadone

Vendramin A., Sciacchitano A. M.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 29 - 34)

Cannabis and Premonitory Symptoms of Schizophrenia: What Is the Time Sequence?

Vernex N., Dagher G., Touzeau D.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 35 - 38)

Alcoholics With a History of Heroin Consumption: Clinical Features and Chronology of Substance Abuse

Ceccanti M., Vitali M.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 39 - 40)

Opioid Dependence and Quality of Life: Changes in the Heroin Epidemic

Domingo-Salvany A.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 41 - 44)

Predictors for Non-Relapsing in Methadone- and Buprenorphine-maintained Heroin Addicts: A Comparative Study

Maremmani I., Pacini M., Lamanna F., Maremmani A. G. I., Pani P. P., Perugi G., Gerra G.

Heroin Addiction and Related Clinical Problems: 2009, 11, 3 (pages: 45 - 48)

Echoing the Patient's Lack of Insight: A Role We Must Avoid Playing

Pacini M.

Heroin Addiction and Related Clinical Problems: 2009, 11, 4 (pages: 5 - 10)

QT Interval

Caldarola P., Cuonzo M.

Heroin Addiction and Related Clinical Problems: 2009, 11, 4 (pages: 11 - 20)

Psychoactive Drugs and Prolongation of the QT Interval

Deruvo G., Vendramin A., Di Sciascio G.

Heroin Addiction and Related Clinical Problems: 2009, 11, 4 (pages: 21 - 28)

Opioid Treatment and “Long-QT Syndrome (LQTS)”: a Critical Review of the Literature

Pacini M., Maremmani A. G. I., Dell' Osso L., Maremmani I.

Heroin Addiction and Related Clinical Problems: 2009, 11, 4 (pages: 29 - 34)

Management of Cardiac Risk during Methadone Treatment: Focus on the QT Interval

Pani P. P.

Heroin Addiction and Related Clinical Problems: 2009, 11, 4 (pages: 35 - 40)

Cardiovascular Complications of Cocaine Use

Gambarana C.

 

EUROPAD - European Opiate Addiction Treatment Association Rolex replica
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page